-
Zexiong WEN
Equity Partner / Chengdu
-
Tel +86-28-6208-8013
Email wenzexiong@zhonglun.com
-
Practices
Chinese Mainland Capital Markets, Investment/M&A & Corporate Governance, Private Equity & Investment Funds
-
Industries
Mining & Natural Resources, Pharmaceuticals & Life Sciences
Zexiong WEN
Mr. Wen focuses on capital markets and has been practicing for over 20 years, especially on full-service legal advice to clients in complex legal matters, including restructuring, initial public offering, refinancing, merger and acquisition, reorganization and restructuring. The industries involved include medicine (including biological medicine), mining, energy, machinery and equipment, chemical, electric power, military, Internet and software, etc. His most representative case is Tianqi Lithium Corporation (002466) acquired the Australian Talison Lithium Pty Ltd in the year of 2014 and won China M&A Gold Wutong for innovative service.
Representative Matters
Representative cases on initial public offering as Issuer’s Legal Counsel:
Advised Sichuan Kelun Pharmaceutical Co., Ltd.(002242) on IPO Projects
Advised Houpu Clean Energy Group Co., Ltd. (300471) on IPO Projects
Advised Yibin Tianyuan Group Co., Ltd. (002386) on IPO Projects
Advised Sichuan Chengfei Integration Technology Corp (002190) on IPO Projects
Advised Chengdu Wintrue Holdings Co., Ltd. (002539) on IPO Projects
Representative cases on M&A, reorganization and restructuring:
Represented Tianqi Lithium Corporation (002466) since its listing on a series of major acquisitions, including the acquisitions of Australian Talison Lithium Pty Ltd. (2014), Galaxy Resources Ltd. (2015), Sociedad Quimica y Minera de Chile S.A.(2018), etc.
Represented Sichuan Kelun Pharmaceutical Co., Ltd.(002242) since its listing on a series of major acquisitions, including the acquisitions of Chengdu Qingshan LiKang Pharmaceutical Co. Ltd., SSY Group Ltd. (02005), Cisen Pharmaceutical Co., Ltd.(603367), etc.
Representative cases on refinancing as Issuer’s Legal Counsel:
Advised Sichuan Kelun Pharmaceutical Co., Ltd.(002242) on public issuance of convertible bonds.
Advised Tianqi Lithium Corporation (002466) on several onshore and offshore refinancings, including A Share Rights Issue, issuance of H shares, issuance of Note, etc.
Advised Emeishan Tourism Co., Ltd.(000888) on Non-public Issuance of Shares.
Advised New Hope Liuhe Co.,Ltd.(000876) on Non-public Issuance of Shares.
Advised Hebei Baoshuo Co., Ltd. (600155) on Non-public Issuance of Shares.
Advised Chengdu Wintrue Holdings Co., Ltd. (002539) on several public or Non-public Issuance.
Advised Chengdu Guibao Science & Technology Co., Ltd. (300019) on Non-public Issuance of Shares.
Advised as standing legal counsel for more than ten listed companies, including Sichuan Kelun Pharmaceutical Co., Ltd.(002242), Chengdu Wintrue Holdings Co., Ltd. (002539), Sichuan Chengfei Integration Technology Corp.Ltd (002190), Tianqi Lithium Corporation (002466), Houpu Clean Energy Group Co., Ltd. (300471), etc.
Honors and Awards
For Individual
Excellent Lawyer of Chengdu, Chengdu Lawyers Association 2011-2014
For Deal
Best Innovative Service in M&A and Reorganization" award & 2015 First China M&A Golden Wutong Award, China M&A Cooperation Alliance and selected by China Securities Journal, Tianqi Lithium Corp (002466) overseas acquisition of Australian Talison Lithium Pty Ltd. project
Related
-
Deals Related
Zhong Lun Advises on Kelun-Biotech's Listing on the Main Board of SEHK
Zhong Lun served as the PRC counsel for the joint sponsors Goldman Sachs (Asia) LLC and CITIC Securities (Hong Kong) Limited, providing legal services throughout the whole of the H shares’ issuance and full circulation.
2023-07-11
-
Bar Admissions/Professional Qualifications
PRC Bar, 1999
-
Education
LL.M., Sichuan University
LL.B., China University of Political Science and Law -
Professional Experience
Associate & Partner, Zhong Lun Law Firm
Associate, King & Wood Mallesons
Associate, Sichuan Hengcheng Law Firm
Associate, Sichuan Zhongchen Law Firm -
Languages
Chinese